BPRN(BPRN)
BPRN
$43.60—Stale · unknown old
NASDAQ • Last print unknown ago
$43.60—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $89M | $92M |
| Low | $89M | $92M |
| High | $89M | $92M |
| EBITDA Avg | $35M | $35M |
| Low | $35M | $34M |
| High | $36M | $36M |
| EBIT Avg | $33M | $33M |
| Low | $33M | $32M |
| High | $33M | $34M |
| Net Income Avg | $26M | $26M |
| Low | $26M | $26M |
| High | $26M | $27M |
| EPS Avg | $3.84 | $3.83 |
| Low | $3.82 | $3.75 |
| High | $3.86 | $3.91 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $22M | $23M | $22M | $23M | $23M | $24M |
| Low | $22M | $23M | $22M | $23M | $23M | $24M |
| High | $22M | $23M | $22M | $23M | $23M | $24M |
| EBITDA Avg | $9M | $9M | $8M | $9M | $9M | $9M |
| Low | $9M | $9M | $8M | $9M | $9M | $9M |
| High | $9M | $9M | $8M | $9M | $9M | $9M |
| EBIT Avg | $8M | $8M | $8M | $8M | $8M | $9M |
| Low | $8M | $8M | $8M | $8M | $8M | $9M |
| High | $8M | $8M | $8M | $8M | $8M | $9M |
| Net Income Avg | $6M | $6M | $6M | $6M | $7M | $7M |
| Low | $6M | $6M | $6M | $6M | $7M | $7M |
| High | $7M | $6M | $6M | $6M | $7M | $7M |
| EPS Avg | $0.95 | $0.94 | $0.91 | $0.93 | $0.98 | $1.01 |
| Low | $0.94 | $0.92 | $0.90 | $0.93 | $0.97 | $1.01 |
| High | $0.96 | $0.95 | $0.91 | $0.94 | $0.98 | $1.02 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |